Literature DB >> 19644533

Pediatric oncology: methotrexate-exploring dosing and administration in ALCL.

John T Sandlund, Joseph H Laver.   

Abstract

Entities:  

Year:  2009        PMID： 19644533     DOI： 10.1038/nrclinonc.2009.107

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.

Authors:  Joseph H Laver; Jacqueline M Kraveka; Robert E Hutchison; Myron Chang; James Kepner; Molly Schwenn; Nancy Tarbell; Sunil Desai; Sheila Weitzman; Howard J Weinstein; Sharon B Murphy
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

2.  Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.

Authors:  Birgit Burkhardt; Wilhelm Woessmann; Martin Zimmermann; Udo Kontny; Josef Vormoor; Wolfgang Doerffel; Georg Mann; Guenter Henze; Felix Niggli; Wolf-Dieter Ludwig; Dirk Janssen; Hansjoerg Riehm; Martin Schrappe; Alfred Reiter
Journal:  J Clin Oncol       Date:  2006-01-20       Impact factor: 44.544

3.  Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study.

Authors:  Joseph H Laver; Hazem Mahmoud; Terry E Pick; Robert E Hutchison; Howard J Weinstein; Molly Schwenn; Sheilah Weitzman; Sharon B Murphy; Stephanie Ochoa; Jonathan J Shuster
Journal:  Leuk Lymphoma       Date:  2002-01

4.  Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

Authors:  Mitchell S Cairo; Mary Gerrard; Richard Sposto; Anne Auperin; C Ross Pinkerton; Jean Michon; Claire Weston; Sherrie L Perkins; Martine Raphael; Keith McCarthy; Catherine Patte
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

5.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Authors:  K Seidemann; M Tiemann; M Schrappe; E Yakisan; I Simonitsch; G Janka-Schaub; W Dörffel; M Zimmermann; G Mann; H Gadner; R Parwaresch; H Riehm; A Reiter
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

7.  Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

Authors:  A Reiter; M Schrappe; M Tiemann; R Parwaresch; M Zimmermann; E Yakisan; R Dopfer; P Bucsky; G Mann; H Gadner
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

8.  CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.

Authors:  L Brugières; M C Deley; H Pacquement; Z Meguerian-Bedoyan; M J Terrier-Lacombe; A Robert; C Pondarré; G Leverger; C Devalck; C Rodary; G Delsol; O Hartmann
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

9.  Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.

Authors:  Laurence Brugières; Marie-Cécile Le Deley; Angelo Rosolen; Denise Williams; Keizo Horibe; Grazyna Wrobel; Georg Mann; Jozsef Zsiros; Anne Uyttebroeck; Ildiko Marky; Laurence Lamant; Alfred Reiter
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544

Review 10.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804
  10 in total
  1 in total

1.  Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy.

Authors:  Ning Zhao; Bingbing Ding; Ying Zhang; Jessica L Klockow; Ken Lau; Frederick T Chin; Zhen Cheng; Hongguang Liu
Journal:  J Control Release       Date:  2020-05-23       Impact factor: 9.776
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.